Disclosures for "Dopaminergic Dysfunction in Movement and Neurocognitive Toxicity (MNT) After CAR-T Therapy: Dopamine Transporter (DaT) Imaging Findings"
-
Dr. Rajarajan has nothing to disclose.
-
Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for A2 Bio. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara. Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iovance. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pierre-Fabre. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
-
An immediate family member of Dr. Ghobrial has received personal compensation for serving as an employee of Disc Medicine . Dr. Ghobrial has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron . Dr. Ghobrial has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron . Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Ghobrial has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite. Dr. Ghobrial has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Predicta Biosciences . Dr. Ghobrial has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker, Presenter with Regeneron .
-
An immediate family member of Dr. Nadeem has received personal compensation for serving as an employee of Sanofi. Dr. Nadeem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JNJ. Dr. Nadeem has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GPCR therapeutics. Dr. Nadeem has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. An immediate family member of Dr. Nadeem has or had stock in Sanofi. The institution of Dr. Nadeem has received research support from JNJ. The institution of Dr. Nadeem has received research support from BMS.
-
Dr. McEntire has nothing to disclose.